- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Influenza
- Meeting Date: August 2019
- Public Summary Document (PSD) August 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) August 2019 PBAC Meeting - (Word 181KB)
Influenza quadrivalent adjuvanted vaccine and Influenza trivalent adjuvanted vaccine – August 2019
INFLUENZA QUADRIVALENT ADJUVANTED VACCINE, Injection 0.5 mL Fluad® Quad, and INFLUENZA TRIVALENT ADJUVANTED VACCINE, Injection 0.5 mL, Fluad®, Seqirus (Australia) Pty Ltd
Last updated
9 July 2025